Coeptis Therapeutics Holdings, Inc.COEPEarnings & Financial Report

Nasdaq · Financials · Finance Services

Deep AnalysisCompare

Coeptis Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies, including cell therapy and antibody-based treatment candidates, to address unmet medical needs for patients with hard-to-treat malignancies. It primarily operates in the U.S., advancing its product pipeline across multiple oncology segments.